Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1897 | 2437 | 44.3 | 87% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
222 | 3 | MYOTONIC DYSTROPHY//ALDOSTERONE//PHYSIOLOGY | 49798 |
1248 | 2 | ALDOSTERONE//GITELMAN SYNDROME//BARTTER SYNDROME | 8969 |
1897 | 1 | ALDOSTERONE//EPLERENONE//SPIRONOLACTONE | 2437 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ALDOSTERONE | authKW | 2878594 | 38% | 25% | 915 |
2 | EPLERENONE | authKW | 1564577 | 8% | 67% | 186 |
3 | SPIRONOLACTONE | authKW | 1219560 | 12% | 34% | 286 |
4 | MINERALOCORTICOID RECEPTOR | authKW | 1192742 | 12% | 32% | 300 |
5 | MINERALOCORTICOID RECEPTOR ANTAGONISTS | authKW | 513388 | 3% | 58% | 71 |
6 | MINERALOCORTICOID | authKW | 264984 | 4% | 21% | 101 |
7 | ALDOSTERONE ANTAGONISTS | authKW | 168392 | 2% | 34% | 40 |
8 | ALDOSTERONE BREAKTHROUGH | authKW | 151230 | 1% | 93% | 13 |
9 | ALDOSTERONE RECEPTOR ANTAGONIST | authKW | 144437 | 1% | 82% | 14 |
10 | ALDOSTERONE BLOCKER | authKW | 124538 | 1% | 76% | 13 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Peripheral Vascular Diseases | 15668 | 24% | 0% | 581 |
2 | Cardiac & Cardiovascular System | 6681 | 21% | 0% | 520 |
3 | Endocrinology & Metabolism | 5543 | 19% | 0% | 467 |
4 | Urology & Nephrology | 2827 | 11% | 0% | 257 |
5 | Physiology | 1649 | 10% | 0% | 239 |
6 | Pharmacology & Pharmacy | 779 | 13% | 0% | 312 |
7 | Cell Biology | 226 | 7% | 0% | 171 |
8 | Medicine, Research & Experimental | 103 | 4% | 0% | 89 |
9 | Medicine, General & Internal | 62 | 4% | 0% | 101 |
10 | Biochemistry & Molecular Biology | 40 | 9% | 0% | 208 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | U478 | 59110 | 1% | 20% | 24 |
2 | JULIUS BERNSTEIN PHYSIOL | 43813 | 1% | 17% | 21 |
3 | STICA | 37584 | 0% | 100% | 3 |
4 | GLOBAL DEV STAT | 34796 | 0% | 56% | 5 |
5 | ENDOCRINOL DIABET HYPERTENS MED | 31699 | 0% | 28% | 9 |
6 | WELLCOME TRUST CELLULAR PHYSIOL UNIT | 29223 | 0% | 33% | 7 |
7 | FEDERATIF RECH CELLULES EPITHELIALES | 28467 | 0% | 45% | 5 |
8 | INVEST CLIN 9501 | 26084 | 0% | 21% | 10 |
9 | CARDIO METAB DIS | 25056 | 0% | 100% | 2 |
10 | CLIN SCI CLIN PHARMACOL CARDIOVASC HEMATOL | 25056 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HYPERTENSION | 29959 | 7% | 1% | 166 |
2 | JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM | 23908 | 2% | 5% | 41 |
3 | CURRENT HYPERTENSION REPORTS | 17272 | 2% | 4% | 38 |
4 | HYPERTENSION RESEARCH | 9725 | 2% | 2% | 44 |
5 | MOLECULAR AND CELLULAR ENDOCRINOLOGY | 4144 | 2% | 1% | 54 |
6 | STEROIDS | 4110 | 2% | 1% | 38 |
7 | AMERICAN JOURNAL OF HYPERTENSION | 3679 | 2% | 1% | 42 |
8 | HEART FAILURE REVIEWS | 3605 | 1% | 2% | 14 |
9 | ENDOCRINOLOGY | 3365 | 3% | 0% | 83 |
10 | CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION | 3122 | 1% | 1% | 20 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ALDOSTERONE | 2878594 | 38% | 25% | 915 | Search ALDOSTERONE | Search ALDOSTERONE |
2 | EPLERENONE | 1564577 | 8% | 67% | 186 | Search EPLERENONE | Search EPLERENONE |
3 | SPIRONOLACTONE | 1219560 | 12% | 34% | 286 | Search SPIRONOLACTONE | Search SPIRONOLACTONE |
4 | MINERALOCORTICOID RECEPTOR | 1192742 | 12% | 32% | 300 | Search MINERALOCORTICOID+RECEPTOR | Search MINERALOCORTICOID+RECEPTOR |
5 | MINERALOCORTICOID RECEPTOR ANTAGONISTS | 513388 | 3% | 58% | 71 | Search MINERALOCORTICOID+RECEPTOR+ANTAGONISTS | Search MINERALOCORTICOID+RECEPTOR+ANTAGONISTS |
6 | MINERALOCORTICOID | 264984 | 4% | 21% | 101 | Search MINERALOCORTICOID | Search MINERALOCORTICOID |
7 | ALDOSTERONE ANTAGONISTS | 168392 | 2% | 34% | 40 | Search ALDOSTERONE+ANTAGONISTS | Search ALDOSTERONE+ANTAGONISTS |
8 | ALDOSTERONE BREAKTHROUGH | 151230 | 1% | 93% | 13 | Search ALDOSTERONE+BREAKTHROUGH | Search ALDOSTERONE+BREAKTHROUGH |
9 | ALDOSTERONE RECEPTOR ANTAGONIST | 144437 | 1% | 82% | 14 | Search ALDOSTERONE+RECEPTOR+ANTAGONIST | Search ALDOSTERONE+RECEPTOR+ANTAGONIST |
10 | ALDOSTERONE BLOCKER | 124538 | 1% | 76% | 13 | Search ALDOSTERONE+BLOCKER | Search ALDOSTERONE+BLOCKER |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | JAISSER, F , FARMAN, N , (2016) EMERGING ROLES OF THE MINERALOCORTICOID RECEPTOR IN PATHOLOGY: TOWARD NEW PARADIGMS IN CLINICAL PHARMACOLOGY.PHARMACOLOGICAL REVIEWS. VOL. 68. ISSUE 1. P. 49 -75 | 201 | 63% | 14 |
2 | HIRSCH, JS , DREXLER, Y , BOMBACK, AS , (2014) ALDOSTERONE BLOCKADE IN CHRONIC KIDNEY DISEASE.SEMINARS IN NEPHROLOGY. VOL. 34. ISSUE 3. P. 307 -322 | 123 | 82% | 10 |
3 | BRIET, M , SCHIFFRIN, EL , (2010) ALDOSTERONE: EFFECTS ON THE KIDNEY AND CARDIOVASCULAR SYSTEM.NATURE REVIEWS NEPHROLOGY. VOL. 6. ISSUE 5. P. 261 -273 | 107 | 78% | 117 |
4 | TAMARGO, J , SOLINI, A , RUILOPE, LM , (2014) COMPARISON OF AGENTS THAT AFFECT ALDOSTERONE ACTION.SEMINARS IN NEPHROLOGY. VOL. 34. ISSUE 3. P. 285 -306 | 120 | 74% | 9 |
5 | HERMIDORFF, M , DE ASSIS, LVM , ISOLDI, MC , (2017) GENOMIC AND RAPID EFFECTS OF ALDOSTERONE: WHAT WE KNOW AND DO NOT KNOW THUS FAR.HEART FAILURE REVIEWS. VOL. 22. ISSUE 1. P. 65 -89 | 149 | 59% | 0 |
6 | BAUERSACHS, J , JAISSER, F , TOTO, R , (2015) MINERALOCORTICOID RECEPTOR ACTIVATION AND MINERALOCORTICOID RECEPTOR ANTAGONIST TREATMENT IN CARDIAC AND RENAL DISEASES.HYPERTENSION. VOL. 65. ISSUE 2. P. 257 -U42 | 85 | 83% | 17 |
7 | MEINEL, S , GEKLE, M , GROSSMANN, C , (2014) MINERALOCORTICOID RECEPTOR SIGNALING: CROSSTALK WITH MEMBRANE RECEPTORS AND OTHER MODULATORS.STEROIDS. VOL. 91. ISSUE . P. 3 -10 | 98 | 80% | 12 |
8 | BROWN, NJ , (2013) CONTRIBUTION OF ALDOSTERONE TO CARDIOVASCULAR AND RENAL INFLAMMATION AND FIBROSIS.NATURE REVIEWS NEPHROLOGY. VOL. 9. ISSUE 8. P. 459-469 | 92 | 73% | 57 |
9 | GROSSMANN, C , GEKLE, M , (2009) NEW ASPECTS OF RAPID ALDOSTERONE SIGNALING.MOLECULAR AND CELLULAR ENDOCRINOLOGY. VOL. 308. ISSUE 1-2. P. 53-62 | 103 | 75% | 65 |
10 | MCCURLEY, A , JAFFE, IZ , (2012) MINERALOCORTICOID RECEPTORS IN VASCULAR FUNCTION AND DISEASE.MOLECULAR AND CELLULAR ENDOCRINOLOGY. VOL. 350. ISSUE 2. P. 256 -265 | 87 | 77% | 51 |
Classes with closest relation at Level 1 |